Evidence map›Paper›PMID 34945136›Full record

ReviewJournal of clinical medicine2021

Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.

Elia Rosi, Maria Thais Fastame, Antonella Di Cesare, Gianmarco Silvi, Nicola Pimpinelli, Francesca Prignano

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Elia RosiDepartment of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.ORCID 0000-0002-4227-7847
Maria Thais FastameDepartment of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.
Antonella Di CesareDepartment of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.
Gianmarco SilviDepartment of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.
Nicola PimpinelliDepartment of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.
Francesca PrignanoDepartment of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.ORCID 0000-0002-5997-2045
University of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Coronavirus Disease 2019 (COVID-19) pandemic, a global public health emergency, has changed dermatology practice and daily routine in just under two years. Much has been written in the literature about COVID-19-associated skin manifestations. Nevertheless, much less has been written regarding skin manifestations in patients affected by severe immune-mediated skin diseases, e.g., psoriasis and hidradenitis suppurativa, undergoing biological treatment during the COVID-19 outbreak. Thus, the aim of this article is to provide the reader with an overview of the cutaneous manifestations during the COVID-19 pandemic in this subset of patients.

Indexed as

acne inversabiologicscoronavirusCOVID-19hidradenitis suppurativapandemicpsoriasisSARS-CoV-2skin manifestations

Identifiers

PMID34945136
PMCPMC8703332
OpenAlexW4200605818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.